Asia Pacific HIV Diagnostics Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Asia Pacific HIV Diagnostics Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Although the most efficient test results are obtained by Enzyme-Linked Immunosorbent Assay (ELISA) test initially and later by Western blot method, HIV diagnosis can be performed by blood test, saliva test, and viral load test. The ELISA test is an enzyme-linked immunosorbent assay and uses antibodies to identify the substance. The Western blot technique is used to detect anti –HIV antibodies in the human serum sample. According to WHO, the HIV diagnosis includes free –standing sites, testing services in health care facilities, some community-based approaches and HIV self-testing (HIVST).
Market Dynamics
Increasing engagement programs by various government bodies to reduce disease burden of HIV epidemics and growing need for safe blood transfusion and donations in Asia Pacific is expected to drive the HIV diagnostic market size during the forecast period. For instance, India plans to make Pre-exposure prophylaxis (PrEP) available to men who have sex with men (MSM) and transgender women. The Indian Council of Medical Research (ICMR) indicated in November 2018 that it is planning to study the effectiveness of PrEP in high-risk groups.
However, stigma and social ostracism associated with HIV infections and diseases is expected to hinder the timely HIV diagnostics and treatment. Moreover, the fear of being tested positive, discrimination, rejection, and stigma restricts several people from conducting screening voluntarily. The fear of discord in marital relationships is yet another challenge where testing HIV positive is often seen as a case of infidelity. Therefore, these factors are expected to hamper the market growth.
Key features of the study:
This report provides in-depth analysis of the Asia Pacific HIV diagnostics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Asia Pacific HIV diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The Asia Pacific HIV diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Asia Pacific HIV Diagnostics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Asia Pacific HIV Diagnostics Market, By Product Type:
Instruments
Reagents & Kits
Asia Pacific HIV Diagnostics Market, By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
Asia Pacific HIV Diagnostics Market, By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
Asia Pacific HIV Diagnostics Market, By Country:
Japan
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
China
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
South Korea
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
ASEAN
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
Australia
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
India
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
Rest of APAC
By Product Type:
Instruments
Reagents & Kits
By Test Type:
Screening
Third Generation
Fourth Generation
Differentiation & Confirmation Test
Monitoring Test
CD4 Tests
Viral Load Tests
By End User:
Hospitals and Clinics
Diagnostic Laboratories
Home Care Settings
Others
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck KGaA
F. Hoffmann-La Roche AG
Atomo Diagnostics
Siemens Healthineers, Inc.
bioLytical Laboratories Inc.
MedMira Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
“*” marked represents similar segmentation in other categories in the respective section.